Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment – a sub-analysis of a randomized, cross-over bioequivalence trial

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-02-07
DOI
https://doi.org/10.1371/journal.pone.0316926
Citations
1
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment – a sub-analysis of a randomized, cross-over bioequivalence trial

Martyn Paddick, John More, Vatsala Rajendram
1 citations
PLoS ONE
Immunodeficiency and Autoimmune Disorders
0.80
article

Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment – a sub-analysis of a randomized, cross-over bioequivalence trial

Martyn Paddick, John More, Vatsala Rajendram
article en
1 citations

Abstract

No abstract available for this paper.
PLoS ONEVol. 20(2)
Bio Products Laboratory (United Kingdom) (GB)
Swinburne University of Technology
Good health and well-being
Openalex Percentile: Top 31%
Immunodeficiency and Autoimmune Disorders
0.80
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment – a sub-analysis of a randomized, cross-over bioequivalence trial — Martyn Paddick, John More, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS